Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 84, 104389
Abstract
No abstract availableKeywords
All Related Versions
This publication has 43 references indexed in Scilit:
- Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly NeutralizingPLOS ONE, 2012
- Coronavirus Escape from Heptad Repeat 2 (HR2)-Derived Peptide Entry Inhibition as a Result of Mutations in the HR1 Domain of the Spike Fusion ProteinJournal of Virology, 2008
- Bats Are Natural Reservoirs of SARS-Like CoronavirusesScience, 2005
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core ComplexJournal of Virology, 2003
- A Novel Coronavirus Associated with Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- Structure validation by Cα geometry: ϕ,ψ and Cβ deviationProteins: Structure, Function, and Bioinformatics, 2003
- Role of Hemagglutinin Cleavage for the Pathogenicity of Influenza VirusVirology, 1999
- Host cell proteases controlling virus pathogenicityTrends in Microbiology, 1994
- Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEVNature, 1992